New therapeutic strategies in the management of systemic sclerosis, Expert Opinion on Pharmacotherapy, vol.46, issue.5, pp.607-615, 2007. ,
DOI : 10.1002/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I
Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma., Journal of Clinical Investigation, vol.98, issue.3, pp.785-792, 1996. ,
DOI : 10.1172/JCI118851
Transcription Factor Fos-Related Antigen-2 Induces Progressive Peripheral Vasculopathy in Mice Closely Resembling Human Systemic Sclerosis, Circulation, vol.120, issue.23, pp.2367-2376, 2009. ,
DOI : 10.1161/CIRCULATIONAHA.109.855114
The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis, Arthritis & Rheumatism, vol.271, issue.1, pp.280-290, 2010. ,
DOI : 10.1002/art.25056
Endothelial Injury in Internal Organs of University of California at Davis Line 200 (UCD 200) Chickens, an Animal Model for Systemic Sclerosis (Scleroderma), Journal of Autoimmunity, vol.14, issue.2, pp.143-149, 2000. ,
DOI : 10.1006/jaut.1999.0355
Experimental models of dermal fibrosis and systemic sclerosis, Joint Bone Spine, vol.80, issue.1, pp.23-28, 2013. ,
DOI : 10.1016/j.jbspin.2012.06.005
Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?, PLoS ONE, vol.182, issue.1, p.1452, 2008. ,
DOI : 10.1371/journal.pone.0001452.t008
Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis, J Rheumatol, vol.27, pp.155-160, 2000. ,
Evaluating microangiopathy in systemic sclerosis: what have we learnt and what is left to discover?, Expert Review of Clinical Immunology, vol.7, issue.4, pp.395-397, 2011. ,
DOI : 10.1586/eci.11.35
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group, Annals of the Rheumatic Diseases, vol.70, issue.3, pp.476-481, 2011. ,
DOI : 10.1136/ard.2010.136929
Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1, Arthritis Research & Therapy, vol.6, issue.4, pp.309-314, 2004. ,
DOI : 10.1186/ar1183
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers, Arthritis Research, vol.4, issue.6, p.11, 2002. ,
DOI : 10.1186/ar596
Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin, Rheumatology, vol.47, issue.7, pp.972-975, 2008. ,
DOI : 10.1093/rheumatology/ken100
Abnormalities in the Regulators of Angiogenesis in Patients with Scleroderma, The Journal of Rheumatology, vol.36, issue.3, pp.576-582, 2009. ,
DOI : 10.3899/jrheum.080516
Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity, Annals of the Rheumatic Diseases, vol.67, issue.10, pp.1455-1460, 2008. ,
DOI : 10.1136/ard.2007.082131
Endothelial progenitor cells and rheumatic disorders, Joint Bone Spine, vol.75, issue.2, pp.131-137, 2008. ,
DOI : 10.1016/j.jbspin.2007.09.006
Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis, Clin Exp Rheumatol, vol.29, pp.46-52, 2011. ,
Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis, Annals of the Rheumatic Diseases, vol.71, issue.3, pp.394-399, 2012. ,
DOI : 10.1136/annrheumdis-2011-200143
Skin score: A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis, Arthritis & Rheumatism, vol.18, issue.8, pp.1256-1263, 1990. ,
DOI : 10.1002/art.1780330828
High N-terminal pro???brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis, Arthritis & Rheumatism, vol.236, issue.1, pp.284-291, 2008. ,
DOI : 10.1002/art.23187
Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies, The Journal of Rheumatology, vol.37, issue.11, pp.2290-2298, 2010. ,
DOI : 10.3899/jrheum.100245
Evidence of cerebral hypoperfusion in scleroderma patients, Rheumatology, vol.39, issue.12, pp.1366-1373, 2000. ,
DOI : 10.1093/rheumatology/39.12.1366
Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients, Annals of the Rheumatic Diseases, vol.67, issue.6, pp.885-887, 2008. ,
DOI : 10.1136/ard.2007.079756
Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry, Cytometry Part B: Clinical Cytometry, vol.24, issue.1, pp.1-8, 2005. ,
DOI : 10.1002/cyto.b.20040
R55 of circulatory vascular endothelial growth factor to endostatin in patients with systemic sclerosis: association with pulmonary involvement, Arthritis Research & Therapy Clin Exp Rheumatol, vol.1515, issue.24, pp.55-508, 2006. ,
Potential biomarkers for detecting pulmonary arterial hypertension in patients with systemic sclerosis, Rheumatology International, vol.105, issue.Suppl, pp.1017-1024, 2009. ,
DOI : 10.1007/s00296-008-0829-8
Serum Tie2 levels: clinical association with microangiopathies in patients with systemic sclerosis, Journal of the European Academy of Dermatology and Venereology, vol.128, issue.Suppl. 3, pp.1476-1479, 2011. ,
DOI : 10.1111/j.1468-3083.2011.04012.x
Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity, Arthritis Research & Therapy, vol.12, issue.1, p.27, 2010. ,
DOI : 10.1186/ar2934
Bone marrow endothelial progenitors are defective in systemic sclerosis, Arthritis & Rheumatism, vol.28, issue.8, pp.2605-2615, 2006. ,
DOI : 10.1002/art.22035
Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis, Arthritis & Rheumatism, vol.30, issue.4, pp.1296-1304, 2004. ,
DOI : 10.1002/art.20116
Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis, Arthritis Research & Therapy, vol.9, issue.Suppl 2, p.3, 2007. ,
DOI : 10.1186/ar2187
Sarcoidosis mimicking lipodermatosclerosis, Cutis, vol.75, pp.322-324, 2005. ,
Potential benefit of statins for vascular disease in systemic sclerosis, Current Opinion in Rheumatology, vol.18, issue.6, pp.594-600, 2006. ,
DOI : 10.1097/01.bor.0000245720.02512.3e
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin, Clinical and Experimental Dermatology, vol.17, issue.3, pp.287-290, 2007. ,
DOI : 10.1111/j.1365-2133.2005.06515.x
Elevated vascular endothelial growth factor in systemic sclerosis, J Rheumatol, vol.30, pp.1529-1533, 2003. ,
Assessment of serum vascular endothelial growth factor and nail fold capillaroscopy changes in systemic lupus erythematosus with and without cutaneous manifestations, The Journal of Dermatology, vol.7, issue.4, pp.52-57, 2012. ,
DOI : 10.1111/j.1346-8138.2011.01322.x
Uncontrolled Expression of Vascular Endothelial Growth Factor and Its Receptors Leads to Insufficient Skin Angiogenesis in Patients With Systemic Sclerosis, Circulation Research, vol.95, issue.1, pp.109-116, 2004. ,
DOI : 10.1161/01.RES.0000134644.89917.96
Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity, Rheumatology, vol.46, issue.10, pp.1566-1569, 2007. ,
DOI : 10.1093/rheumatology/kem190
Capillaroscopic skin ulcer risk index: A new prognostic tool for digital skin ulcer development in systemic sclerosis patients, Arthritis & Rheumatism, vol.5, issue.5, pp.688-694, 2009. ,
DOI : 10.1002/art.24394
Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study, Annals of the Rheumatic Diseases, vol.71, issue.1, pp.67-70, 2012. ,
DOI : 10.1136/annrheumdis-2011-200022
Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions, Annals of the Rheumatic Diseases, vol.70, issue.1, pp.180-183, 2011. ,
DOI : 10.1136/ard.2010.132431